For ER-HER2+ breast cancer, mean time to RNA-Seq was 29.3 months (range 5.5-69.7) compared with 4.3 months (range 0.0-36.7) for ER-HER2- breast cancer. This evidence concerns the gene ESR1 and breast cancer.